Coastview Capital
4
41M
4
1
2
- Stages of investment
- Areas of investment
Summary
The venture was found in North America in United States. The main office of represented VC is situated in the Los Angeles.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Coastview Capital, startups are often financed by Sanderling Ventures, RCT BioVentures, Novartis Venture Fund. The meaningful sponsors for the fund in investment in the same round are MPM Capital, Flagship Pioneering, William Harris Investors. In the next rounds fund is usually obtained by Lilly Ventures, HBM Healthcare Investments AG, Bioventures Investors.
Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Coastview Capital performs on 38 percentage points more the average number of lead investments. The fund is generally included in less than 2 deals every year. The top amount of exits for fund were in 2010. The top activity for fund was in 2005. The common things for fund are deals in the range of 10 - 50 millions dollars.
Among the most popular portfolio startups of the fund, we may highlight Cylene Pharmaceuticals, Hypnion, CGI Pharmaceuticals. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Health Diagnostics, Medical. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 1
- Exits
- 2
- Investments by industry
- Biotechnology (4)
- Health Care (3)
- Pharmaceutical (2)
- Medical (1)
- Health Diagnostics (1) Show 2 more
- Investments by region
-
- United States (4)
- Peak activity year
- 2005
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 23
- Avg. valuation at time of investment
- 63M
- Group Appearance index
- 1.00
- Avg. company exit year
- 13
- Avg. multiplicator
- 1.54
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Cylene Pharmaceuticals | 26 May 2005 | Biotechnology, Health Care, Pharmaceutical | Early Stage Venture | 26M | United States, California, San Diego |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.